Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150.
作者信息
Espinoza Magdalena, Muquith Maishara, Lim Mir, Zhu Hao, Singal Amit G, Hsiehchen David
机构信息
Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
出版信息
Gastroenterology. 2023 Jul;165(1):286-288.e4. doi: 10.1053/j.gastro.2023.02.042. Epub 2023 Mar 7.
PMID:36894034
Abstract
摘要
Zotero 插件